First successful demonstration of Sosei's drug reprofiling approach: DRP-001 enters phase I for UI Nov. 21, 2001
GSK and Bayer sign worldwide copromotion agreement for vardenafil in erectile dysfunction Nov. 16, 2001
Carbamic acid-based IP receptor antagonists reportedly useful for bladder disorders, etc. Nov. 9, 2001
RSS